img

Global Intramuscular HPV Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intramuscular HPV Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body's immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
Intramuscular HPV Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intramuscular HPV Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Male and Female are the major drivers for the industry.
The characteristics and precautions of intramuscular injection of HPV vaccine includerecommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intramuscular HPV Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
Segment by Type
Bivalent
Quadrivalent
Nine-valent

Segment by Application


Male
Female

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intramuscular HPV Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intramuscular HPV Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intramuscular HPV Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Intramuscular HPV Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intramuscular HPV Vaccine introduction, etc. Intramuscular HPV Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Intramuscular HPV Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Intramuscular HPV Vaccine Market Overview
1.1 Intramuscular HPV Vaccine Product Overview
1.2 Intramuscular HPV Vaccine Market Segment by Type
1.2.1 Bivalent
1.2.2 Quadrivalent
1.2.3 Nine-valent
1.3 Global Intramuscular HPV Vaccine Market Size by Type
1.3.1 Global Intramuscular HPV Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Intramuscular HPV Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Intramuscular HPV Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intramuscular HPV Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Intramuscular HPV Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Intramuscular HPV Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Intramuscular HPV Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Intramuscular HPV Vaccine Sales Breakdown by Type (2018-2024)
2 Global Intramuscular HPV Vaccine Market Competition by Company
2.1 Global Top Players by Intramuscular HPV Vaccine Sales (2018-2024)
2.2 Global Top Players by Intramuscular HPV Vaccine Revenue (2018-2024)
2.3 Global Top Players by Intramuscular HPV Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Intramuscular HPV Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intramuscular HPV Vaccine Market Competitive Situation and Trends
2.5.1 Intramuscular HPV Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Intramuscular HPV Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular HPV Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Intramuscular HPV Vaccine Market
2.8 Key Manufacturers Intramuscular HPV Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intramuscular HPV Vaccine Status and Outlook by Region
3.1 Global Intramuscular HPV Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intramuscular HPV Vaccine Historic Market Size by Region
3.2.1 Global Intramuscular HPV Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Intramuscular HPV Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Intramuscular HPV Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Intramuscular HPV Vaccine Forecasted Market Size by Region
3.3.1 Global Intramuscular HPV Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Intramuscular HPV Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Intramuscular HPV Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intramuscular HPV Vaccine by Application
4.1 Intramuscular HPV Vaccine Market Segment by Application
4.1.1 Male
4.1.2 Female
4.2 Global Intramuscular HPV Vaccine Market Size by Application
4.2.1 Global Intramuscular HPV Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Intramuscular HPV Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Intramuscular HPV Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intramuscular HPV Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Intramuscular HPV Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Intramuscular HPV Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Intramuscular HPV Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Intramuscular HPV Vaccine Sales Breakdown by Application (2018-2024)
5 North America Intramuscular HPV Vaccine by Country
5.1 North America Intramuscular HPV Vaccine Historic Market Size by Country
5.1.1 North America Intramuscular HPV Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intramuscular HPV Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Intramuscular HPV Vaccine Sales in Value by Country (2018-2024)
5.2 North America Intramuscular HPV Vaccine Forecasted Market Size by Country
5.2.1 North America Intramuscular HPV Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Intramuscular HPV Vaccine Sales in Value by Country (2024-2029)
6 Europe Intramuscular HPV Vaccine by Country
6.1 Europe Intramuscular HPV Vaccine Historic Market Size by Country
6.1.1 Europe Intramuscular HPV Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intramuscular HPV Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Intramuscular HPV Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Intramuscular HPV Vaccine Forecasted Market Size by Country
6.2.1 Europe Intramuscular HPV Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Intramuscular HPV Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Intramuscular HPV Vaccine by Region
7.1 Asia-Pacific Intramuscular HPV Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Intramuscular HPV Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intramuscular HPV Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Intramuscular HPV Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Intramuscular HPV Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Intramuscular HPV Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intramuscular HPV Vaccine Sales in Value by Region (2024-2029)
8 Latin America Intramuscular HPV Vaccine by Country
8.1 Latin America Intramuscular HPV Vaccine Historic Market Size by Country
8.1.1 Latin America Intramuscular HPV Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intramuscular HPV Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Intramuscular HPV Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Intramuscular HPV Vaccine Forecasted Market Size by Country
8.2.1 Latin America Intramuscular HPV Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intramuscular HPV Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Intramuscular HPV Vaccine by Country
9.1 Middle East and Africa Intramuscular HPV Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Intramuscular HPV Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intramuscular HPV Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Intramuscular HPV Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Intramuscular HPV Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Intramuscular HPV Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intramuscular HPV Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck Sharp & Dohme (MSD)
10.1.1 Merck Sharp & Dohme (MSD) Company Information
10.1.2 Merck Sharp & Dohme (MSD) Introduction and Business Overview
10.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Products Offered
10.1.5 Merck Sharp & Dohme (MSD) Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Intramuscular HPV Vaccine Products Offered
10.2.5 Pfizer Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Intramuscular HPV Vaccine Products Offered
10.3.5 Sanofi Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GSK Intramuscular HPV Vaccine Products Offered
10.4.5 GSK Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Serum Institute Intramuscular HPV Vaccine Products Offered
10.5.5 Serum Institute Recent Development
10.6 Astellas Pharma
10.6.1 Astellas Pharma Company Information
10.6.2 Astellas Pharma Introduction and Business Overview
10.6.3 Astellas Pharma Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Astellas Pharma Intramuscular HPV Vaccine Products Offered
10.6.5 Astellas Pharma Recent Development
10.7 CSL
10.7.1 CSL Company Information
10.7.2 CSL Introduction and Business Overview
10.7.3 CSL Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 CSL Intramuscular HPV Vaccine Products Offered
10.7.5 CSL Recent Development
10.8 Emergent BioSolutions
10.8.1 Emergent BioSolutions Company Information
10.8.2 Emergent BioSolutions Introduction and Business Overview
10.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Products Offered
10.8.5 Emergent BioSolutions Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Johnson & Johnson Intramuscular HPV Vaccine Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 MedImmune
10.11.1 MedImmune Company Information
10.11.2 MedImmune Introduction and Business Overview
10.11.3 MedImmune Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 MedImmune Intramuscular HPV Vaccine Products Offered
10.11.5 MedImmune Recent Development
10.12 Walvax Biotechnology
10.12.1 Walvax Biotechnology Company Information
10.12.2 Walvax Biotechnology Introduction and Business Overview
10.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Products Offered
10.12.5 Walvax Biotechnology Recent Development
10.13 Liaoning Chengda Biotechnology
10.13.1 Liaoning Chengda Biotechnology Company Information
10.13.2 Liaoning Chengda Biotechnology Introduction and Business Overview
10.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Products Offered
10.13.5 Liaoning Chengda Biotechnology Recent Development
10.14 Hualan Biological Engineering
10.14.1 Hualan Biological Engineering Company Information
10.14.2 Hualan Biological Engineering Introduction and Business Overview
10.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Products Offered
10.14.5 Hualan Biological Engineering Recent Development
10.15 Sinovac Biotech
10.15.1 Sinovac Biotech Company Information
10.15.2 Sinovac Biotech Introduction and Business Overview
10.15.3 Sinovac Biotech Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Sinovac Biotech Intramuscular HPV Vaccine Products Offered
10.15.5 Sinovac Biotech Recent Development
10.16 Chongqing Zhifei Biological Products
10.16.1 Chongqing Zhifei Biological Products Company Information
10.16.2 Chongqing Zhifei Biological Products Introduction and Business Overview
10.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Products Offered
10.16.5 Chongqing Zhifei Biological Products Recent Development
10.17 Chang Chun High and New Technology Industries (Group)
10.17.1 Chang Chun High and New Technology Industries (Group) Company Information
10.17.2 Chang Chun High and New Technology Industries (Group) Introduction and Business Overview
10.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Products Offered
10.17.5 Chang Chun High and New Technology Industries (Group) Recent Development
10.18 Beijing Wantai Biological Pharmacy Enterprise
10.18.1 Beijing Wantai Biological Pharmacy Enterprise Company Information
10.18.2 Beijing Wantai Biological Pharmacy Enterprise Introduction and Business Overview
10.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Products Offered
10.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Development
10.19 Jiangsu Recbio Technology
10.19.1 Jiangsu Recbio Technology Company Information
10.19.2 Jiangsu Recbio Technology Introduction and Business Overview
10.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Products Offered
10.19.5 Jiangsu Recbio Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intramuscular HPV Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intramuscular HPV Vaccine Industrial Chain Analysis
11.4 Intramuscular HPV Vaccine Market Dynamics
11.4.1 Intramuscular HPV Vaccine Industry Trends
11.4.2 Intramuscular HPV Vaccine Market Drivers
11.4.3 Intramuscular HPV Vaccine Market Challenges
11.4.4 Intramuscular HPV Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intramuscular HPV Vaccine Distributors
12.3 Intramuscular HPV Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bivalent
Table 2. Major Company of Quadrivalent
Table 3. Major Company of Nine-valent
Table 4. Global Intramuscular HPV Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Intramuscular HPV Vaccine Sales by Type (2018-2024) & (Units)
Table 6. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Intramuscular HPV Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Intramuscular HPV Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Intramuscular HPV Vaccine Sales by Type (2024-2029) & (Units)
Table 11. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Intramuscular HPV Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Intramuscular HPV Vaccine Sales Market Share in Value by Type (2024-2029)
Table 14. Global Intramuscular HPV Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Intramuscular HPV Vaccine Sales by Type (2018-2024) & (Units)
Table 16. North America Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Intramuscular HPV Vaccine Sales (Units) by Type (2018-2024)
Table 18. Europe Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Intramuscular HPV Vaccine Sales (Units) by Type (2018-2024)
Table 20. Asia-Pacific Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Intramuscular HPV Vaccine Sales (Units) by Type (2018-2024)
Table 22. Latin America Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Intramuscular HPV Vaccine Sales (Units) by Type (2018-2024)
Table 24. Middle East and Africa Intramuscular HPV Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Intramuscular HPV Vaccine Sales by Company (2018-2024) & (Units)
Table 26. Global Intramuscular HPV Vaccine Sales Share by Company (2018-2024)
Table 27. Global Intramuscular HPV Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Intramuscular HPV Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Intramuscular HPV Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Intramuscular HPV Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Intramuscular HPV Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intramuscular HPV Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Intramuscular HPV Vaccine Market
Table 34. Key Manufacturers Intramuscular HPV Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Intramuscular HPV Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Intramuscular HPV Vaccine Sales by Region (2018-2024) & (Units)
Table 38. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Intramuscular HPV Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Intramuscular HPV Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Intramuscular HPV Vaccine Sales by Region (2024-2029) & (Units)
Table 43. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Intramuscular HPV Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Intramuscular HPV Vaccine Sales Market Share in Value by Region (2024-2029)
Table 46. Global Intramuscular HPV Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Intramuscular HPV Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Intramuscular HPV Vaccine Sales by Application (2018-2024) & (Units)
Table 49. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Intramuscular HPV Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Intramuscular HPV Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Intramuscular HPV Vaccine Sales by Application (2024-2029) & (Units)
Table 54. Global Intramuscular HPV Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Intramuscular HPV Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Intramuscular HPV Vaccine Sales Market Share in Value by Application (2024-2029)
Table 57. Global Intramuscular HPV Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Intramuscular HPV Vaccine Sales by Application (2018-2024) (Units)
Table 59. North America Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Intramuscular HPV Vaccine Sales by Application (2018-2024) (Units)
Table 61. Europe Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Intramuscular HPV Vaccine Sales by Application (2018-2024) (Units)
Table 63. Asia-Pacific Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Intramuscular HPV Vaccine Sales by Application (2018-2024) (Units)
Table 65. Latin America Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Intramuscular HPV Vaccine Sales by Application (2018-2024) (Units)
Table 67. Middle East and Africa Intramuscular HPV Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 69. North America Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Intramuscular HPV Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 73. North America Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Intramuscular HPV Vaccine Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 77. Europe Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Intramuscular HPV Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Intramuscular HPV Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 81. Europe Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Intramuscular HPV Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Intramuscular HPV Vaccine Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Intramuscular HPV Vaccine Sales by Region (2018-2024) & (Units)
Table 85. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Intramuscular HPV Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Intramuscular HPV Vaccine Sales by Region (2024-2029) & (Units)
Table 89. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Intramuscular HPV Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 93. Latin America Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Intramuscular HPV Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Intramuscular HPV Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 97. Latin America Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Intramuscular HPV Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Intramuscular HPV Vaccine Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2018-2024) & (Units)
Table 101. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2024-2029) & (Units)
Table 105. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Value by Country (2024-2029)
Table 108. Merck Sharp & Dohme (MSD) Company Information
Table 109. Merck Sharp & Dohme (MSD) Introduction and Business Overview
Table 110. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product
Table 112. Merck Sharp & Dohme (MSD) Recent Development
Table 113. Pfizer Company Information
Table 114. Pfizer Introduction and Business Overview
Table 115. Pfizer Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Pfizer Intramuscular HPV Vaccine Product
Table 117. Pfizer Recent Development
Table 118. Sanofi Company Information
Table 119. Sanofi Introduction and Business Overview
Table 120. Sanofi Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Sanofi Intramuscular HPV Vaccine Product
Table 122. Sanofi Recent Development
Table 123. GSK Company Information
Table 124. GSK Introduction and Business Overview
Table 125. GSK Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. GSK Intramuscular HPV Vaccine Product
Table 127. GSK Recent Development
Table 128. Serum Institute Company Information
Table 129. Serum Institute Introduction and Business Overview
Table 130. Serum Institute Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Serum Institute Intramuscular HPV Vaccine Product
Table 132. Serum Institute Recent Development
Table 133. Astellas Pharma Company Information
Table 134. Astellas Pharma Introduction and Business Overview
Table 135. Astellas Pharma Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Astellas Pharma Intramuscular HPV Vaccine Product
Table 137. Astellas Pharma Recent Development
Table 138. CSL Company Information
Table 139. CSL Introduction and Business Overview
Table 140. CSL Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. CSL Intramuscular HPV Vaccine Product
Table 142. CSL Recent Development
Table 143. Emergent BioSolutions Company Information
Table 144. Emergent BioSolutions Introduction and Business Overview
Table 145. Emergent BioSolutions Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Emergent BioSolutions Intramuscular HPV Vaccine Product
Table 147. Emergent BioSolutions Recent Development
Table 148. GlaxoSmithKline Company Information
Table 149. GlaxoSmithKline Introduction and Business Overview
Table 150. GlaxoSmithKline Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. GlaxoSmithKline Intramuscular HPV Vaccine Product
Table 152. GlaxoSmithKline Recent Development
Table 153. Johnson & Johnson Company Information
Table 154. Johnson & Johnson Introduction and Business Overview
Table 155. Johnson & Johnson Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Johnson & Johnson Intramuscular HPV Vaccine Product
Table 157. Johnson & Johnson Recent Development
Table 158. MedImmune Company Information
Table 159. MedImmune Introduction and Business Overview
Table 160. MedImmune Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. MedImmune Intramuscular HPV Vaccine Product
Table 162. MedImmune Recent Development
Table 163. Walvax Biotechnology Company Information
Table 164. Walvax Biotechnology Introduction and Business Overview
Table 165. Walvax Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Walvax Biotechnology Intramuscular HPV Vaccine Product
Table 167. Walvax Biotechnology Recent Development
Table 168. Liaoning Chengda Biotechnology Company Information
Table 169. Liaoning Chengda Biotechnology Introduction and Business Overview
Table 170. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product
Table 172. Liaoning Chengda Biotechnology Recent Development
Table 173. Hualan Biological Engineering Company Information
Table 174. Hualan Biological Engineering Introduction and Business Overview
Table 175. Hualan Biological Engineering Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Hualan Biological Engineering Intramuscular HPV Vaccine Product
Table 177. Hualan Biological Engineering Recent Development
Table 178. Sinovac Biotech Company Information
Table 179. Sinovac Biotech Introduction and Business Overview
Table 180. Sinovac Biotech Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Sinovac Biotech Intramuscular HPV Vaccine Product
Table 182. Sinovac Biotech Recent Development
Table 183. Chongqing Zhifei Biological Products Company Information
Table 184. Chongqing Zhifei Biological Products Introduction and Business Overview
Table 185. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product
Table 187. Chongqing Zhifei Biological Products Recent Development
Table 188. Chang Chun High and New Technology Industries (Group) Company Information
Table 189. Chang Chun High and New Technology Industries (Group) Introduction and Business Overview
Table 190. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product
Table 192. Chang Chun High and New Technology Industries (Group) Recent Development
Table 193. Beijing Wantai Biological Pharmacy Enterprise Company Information
Table 194. Beijing Wantai Biological Pharmacy Enterprise Introduction and Business Overview
Table 195. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product
Table 197. Beijing Wantai Biological Pharmacy Enterprise Recent Development
Table 198. Jiangsu Recbio Technology Company Information
Table 199. Jiangsu Recbio Technology Introduction and Business Overview
Table 200. Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product
Table 202. Jiangsu Recbio Technology Recent Development
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Intramuscular HPV Vaccine Market Trends
Table 206. Intramuscular HPV Vaccine Market Drivers
Table 207. Intramuscular HPV Vaccine Market Challenges
Table 208. Intramuscular HPV Vaccine Market Restraints
Table 209. Intramuscular HPV Vaccine Distributors List
Table 210. Intramuscular HPV Vaccine Downstream Customers
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Intramuscular HPV Vaccine Product Picture
Figure 2. Global Intramuscular HPV Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Intramuscular HPV Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Intramuscular HPV Vaccine Sales Status and Outlook (2018-2029) & (Units)
Figure 5. Product Picture of Bivalent
Figure 6. Global Bivalent Sales YoY Growth (2018-2029) & (Units)
Figure 7. Product Picture of Quadrivalent
Figure 8. Global Quadrivalent Sales YoY Growth (2018-2029) & (Units)
Figure 9. Product Picture of Nine-valent
Figure 10. Global Nine-valent Sales YoY Growth (2018-2029) & (Units)
Figure 11. Global Intramuscular HPV Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Intramuscular HPV Vaccine Sales Market Share by Type in 2022 & 2029
Figure 13. North America Intramuscular HPV Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Intramuscular HPV Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Intramuscular HPV Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Intramuscular HPV Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Intramuscular HPV Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Intramuscular HPV Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Intramuscular HPV Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Intramuscular HPV Vaccine Revenue in 2022
Figure 25. Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Male
Figure 27. Global Male Sales YoY Growth (2018-2029) & (Units)
Figure 28. Product Picture of Female
Figure 29. Global Female Sales YoY Growth (2018-2029) & (Units)
Figure 30. Global Intramuscular HPV Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Intramuscular HPV Vaccine Sales Market Share by Application in 2022 & 2029
Figure 32. North America Intramuscular HPV Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Intramuscular HPV Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Intramuscular HPV Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Intramuscular HPV Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Intramuscular HPV Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Intramuscular HPV Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Intramuscular HPV Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Intramuscular HPV Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Intramuscular HPV Vaccine Manufacturing Cost Structure
Figure 43. Intramuscular HPV Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries